Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer

Clinical Trial ID NCT01342224

Rank	Title	Journal	Year	PubWeight™‹?›
1	Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.	J Immunother Cancer	2013	1.35
2	Trial Watch: Anticancer radioimmunotherapy.	Oncoimmunology	2013	1.31
3	Trial watch: Peptide vaccines in cancer therapy.	Oncoimmunology	2012	1.17
4	Current clinical trials testing combinations of immunotherapy and radiation.	Semin Radiat Oncol	2015	1.11
5	Immunotherapy updates in pancreatic cancer: are we there yet?	Ther Adv Med Oncol	2013	1.00
6	New targeted therapies in pancreatic cancer.	World J Gastroenterol	2015	0.87
7	Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.	Oncoimmunology	2016	0.84
8	Systemic Chemotherapy in Advanced Pancreatic Cancer.	Gut Liver	2016	0.81
9	Telomere and Telomerase Therapeutics in Cancer.	Genes (Basel)	2016	0.81
10	A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.	J Immunother Cancer	2016	0.76